
News|Videos|May 22, 2023
Evolution of Pharmacological Treatments at the 2023 APA Annual Meeting
Author(s)John J. Miller, MD
An inside look at what treatments are being discussed in San Francisco...
Advertisement
CONFERENCE REPORTER
What exciting treatments are being discussed at the APA Annual meeting this year? Psychiatric Times Editor-in-Chief, John J. Miller, MD, gives an overview.
What new treatments are you interested in? Let us know at
Dr Miller is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times; Staff Psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Exeter Hospital, Exeter; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us
2
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
3
Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement
4
Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD
5











